Careers
Working Here
Mission & Purpose
Culture
Diversity & Inclusion
Career Growth & Colleague Development
Compensation & Benefits
Ensuring Corporate Responsibility
Search Jobs
Student & Early Career
Postdoctoral Program
US Summer Student Worker Program
Opportunities for Veterans
Pfizer365.com
Our Hiring & Recruiting Process
Frequently Asked Questions
Tips for Interviewing at Pfizer
Connect With Us
Investors
Investors Overview
Why Invest / Our Story
Prospective Investors
Fact Sheet
Events & Presentations
Financials
Quarterly Reports
Annual Reports
SEC Filings
Interactive Data Filings
Investor News
Stock Information
Historical Stock Chart & Data
Investment Calculator
Historical Price Lookup
Dividend & Split History
Stock FAQs
Governance
Board Committees and Charters
The Pfizer Board Policies
Corporate Governance FAQs
Contact Our Directors
Shareholder Services
Stock FAQs
Cost Basis Calculator
Advisory Information
News
Press Release Archive
Press Statements
Contact Media Relations
Press Kits & Downloads
Partners
Health Professionals
Connect with Us
Email
FAQ
Privacy Policy (NEW)
YouTube
Twitter
Facebook
LinkedIn
Instagram
Your Health
Healthy Living
Brain & Nervous System
Cardiovascular Health
Cold & Flu
Digestive Health
Healthier Aging
Living Tobacco Free
Men’s Health
Mental Health
Nutrition & Fitness
Pediatric Health
Respiratory Health
Skin Health
Vaccines & Prevention
Women’s Health
Disease & Condition
Cancer
Cardiovascular Diseases & Conditions
Diabetes & Metabolic Disorders
Immune System Diseases & Conditions
Infections & Infectious Diseases
Neurological Diseases & Conditions
Menopause
Rare Disease
Vaccine-Related Conditions
Skin Diseases & Conditions
Managing your health
Caregiving
Evaluating Health Information
Tracking Your Health
Your Medicines
Health Literacy
Wellness
Hot Topics
Hot Topics
Three Things to Know About VTE
Our Science
Driven to Discover the cure
Focus Areas
Internal Medicine
Inflammation & Immunology
Oncology
Rare Disease
Vaccines
Anti-Infectives
Product Pipeline
Clinical Trials
What are Clinical Trials?
How Clinical Trials are Conducted
Find a trial
Compassionate Use & Expanded Access
Clinical Innovation
Pediatric Research
Trial Data & Results
Post Marketing Commitments
Pediatric Trials
R&D Platforms
Biosimilars
Gene Therapy
Medicinal Sciences
Precision Medicine
Collaboration
Competitive Grants
Independent Grants
Compound Transfer Program
Partner with Pfizer
Research sites
Hot Topics
Inspiring the Next Generation
All about the PfIRe Lab here:
Our People
Meet The Experts
Scientists
Internal Medicine – Metabolic Disease
Inflammation & Immunology
Oncology
Rare Disease
Vaccines
Medical Professionals
The Journey
Leadership
Executives
Board Members
Company Fact Sheet
Diverse Perspectives
Diversity & Inclusion
Supplier Diversity
Hot Topics
New Podcast Takes a Deep Dive into the Story of Vaccines
A Day In The Life of Our Scientist
Our Purpose
Commitment to Global Health
Expanding Access
Strengthening Health Systems
Providing Disaster & Humanitarian Relief
Unleashing the Power of Our Colleagues
Highlighting Individual Voices
Protecting People and the Environment
Pfizer's Green Journey
Product Stewardship
EHS Governance
EHS Supply Chain
Key Performance Indicators
Health & Safety
Positions on Health Policies
Ready for Cures
How does Pfizer price medicines?
Value of Medicines
Policy Positions
Creating Cures Through Facility Investments
Transparency
Working with Health Care Professionals
Transparency in Grants
Code of Conduct
Corporate Compliance
Sales and Marketing Compliance
Independent Grants
Investigator Sponsored Research
Quality Improvement
Independent Medical Education
Competitive Grants Program
Contributions & Partnerships
Healthcare Charitable Contributions
Special Charity Events
Lobbying & Political Contributions
Hot Topics
Reducing Health Disparities in Latino Communities
Our Products
Product listing
How drugs are made
Branded vs. Generic
Biologics & Biosimilars
Commitment to Quality
Upjohn
About Upjohn
Portfolio of Brands
Manufacturing Plants
UpJohn Leadership
Distributors
Pfizer Distributors
Greenstone Distributors
Medicine Safety
Reporting Adverse Events
Making Good Treatment Choices
Partnering With Patients
Health Literacy
Medicine Safety Tips for Patients
Counterfeiting
Unused Medicines
Material Safety Data Sheets
Medical Information Contacts
Pfizer Global Supply
Hot Topics
Universal vs. Single Payer Healthcare
Counterfeit Medicines - Is The Threat Real Or Fake
You are here
News
/
Press Statements
Press Statements
11.15.2019
Pfizer Announces CHMP Opinion for XELJANZ® (tofacitinib) in the European Union Related to Ongoing Review of the Product
10.18.2019
Pfizer Statement on Vincristine Sulfate Injection, USP Supply in the United States
10.17.2019
Pfizer Statement on Results of Pay Equity Study and Opportunity Parity Among Colleagues Worldwide
09.17.2019
TrialSpark and Pfizer collaborating to improve speed and access to clinical trials
09.17.2019
Terry Bradshaw and Pfizer Educate Boomers About the Risks of Pneumococcal Pneumonia and the Importance of Vaccination
09.12.2019
Catalia Health and Pfizer collaborate to better understand patient journeys using artificial intelligence and via robot wellness coach
09.06.2019
Hospira, Inc., Issues A Voluntary Nationwide Recall for one lot of BACTERIOSTATIC WATER for Injection, USP, due to a Potential Lack of Sterility Assurance.
09.01.2019
Findings Released from NAXOS, a French Real-World Data Analysis and the Largest Real-World Data Analysis on Oral Anticoagulant Effectiveness and Safety in Europe Among Patients with Non-Valvular Atrial Fibrillation
08.14.2019
Pfizer Inc. Issues A Voluntary Nationwide Recall For 2 Lots of RELPAX® (eletriptan hydrobromide) 40 mg Tablets Due to Potential Microbiological Contamination of Non-Sterile Products
07.26.2019
Pfizer Statement on Update to XELJANZ® (tofacitinib) Prescribing Information in the United States
06.26.2019
Pfizer Responds to the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention’s Vote to Revise the Recommendation for Routine Use of Prevnar 13® for the Prevention of Pneumococcal Disease for Adults 65 Years or Older
05.17.2019
Pfizer confirms initiation of EU review of Tofacitinib with interim recommendations
04.26.2019
Pfizer Inc. Issues A Voluntary Nationwide Consumer Level Recall of One Lot of ThermaCare® Back Pain Therapy HeatWraps, up to 16HR pain relief, Due To Out of Specification Results for High Cell Temperature
03.18.2019
Hospira, Inc. Issues A Voluntary Nationwide Recall of 8.4% Sodium Bicarbonate Injection, USP Due To The Presence of Particulate Matter.
02.19.2019
Pfizer Announces Modification To Ongoing Tofacitinib FDA Post-Marketing Requirement Study In Patients With Rheumatoid Arthritis
11.26.2018
Pfizer Inc. Issues A Voluntary Nationwide Consumer Level Recall Of Six Lots Of ThermaCare® HeatWraps Due To Leaking Wraps with the Potential For Skin Injuries
11.16.2018
Pfizer Provides Transparency On Drug Prices In The U.S. 90 Percent Of Company’s Prices Will Remain Unchanged
11.11.2018
Real-World Evidence on Patients Aged 80 and Older Presented From ARISTOPHANES, the Largest Real-World Data Study Evaluating Oral Anticoagulants Among Patients with Non-Valvular Atrial Fibrillation
11.09.2018
Data From Phase 2 PALLET Study of IBRANCE® (palbociclib)in Early Breast Cancer to be Presented at San Antonio Breast Cancer Symposium
10.18.2018
Pfizer Announces Initiation of Phase 3 Trial of Tofacitinib in Patients with Ankylosing Spondylitis
1 of 5
next ›
Press Release Archive
Press Statements
Contact Media Relations
Press Kits & Downloads
Company Press Kit
Podcasts
The Antigen Podcast
Diverse Perspectives Podcast
Get Science Podcast
Breast Cancer: A Story Half Told Press Kit
Get Old Press Kit
Pfizer Oncology Press Kit
PSA Narrative
RA NarRAtive
Rare Disease Gene Therapy Press Kit
TTR-Amyloidosis Press Kit
UC Narrative
Online Pfizer Press Kit
Company Press Kit
View the Pfizer Company Press Kit
Press Statements
View Pfizer's latest press statements